Allison Hanley Papp, PT, DPT | |
5680 Venture Dr, Dublin, OH 43017-2190 | |
(614) 355-8752 | |
Not Available |
Full Name | Allison Hanley Papp |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 5680 Venture Dr, Dublin, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063869642 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | PT016276 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Allison Hanley Papp, PT, DPT 5680 Venture Dr, Dublin, OH 43017-2190 Ph: (614) 355-8752 | Allison Hanley Papp, PT, DPT 5680 Venture Dr, Dublin, OH 43017-2190 Ph: (614) 355-8752 |
News Archive
Even while the recent outbreak of acute serious lung disease in vapers is challenging the skill and technology of the medical field, a new report published in the journal JAMA Internal Medicine on September 16, 2019, says that a natural plant oil called pulegone, which is used to impart a minty flavor to e-cigarettes, could quite possibly be carcinogenic at the levels found in these devices.
Today, at an expert meeting on the future use of dental fillings, a letter signed by over 70 non-governmental organisations from around the world was presented, calling on the World Health Organization (WHO) to establish a schedule to phase out the use of dental mercury fillings as soon as possible.
Theoretical physicists led by Professor Kurt Binder and Dr. Arash Nikoubashman at Johannes Gutenberg University Mainz in Germany have used computer simulations to study the arrangement of stiff polymers in spherical cavities.
Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.
Texas A&M Institute for Genomic Medicine (TIGM) – a research institute of the Texas A&M Health Science Center – has created a grant-in-aid program specifically to assist University of Texas Medical Branch at Galveston (UTMB) scientists obtain access to research materials in an effort to help speed the recovery of UTMB's research programs from some of the injuries caused by Hurricane Ike.
› Verified 1 days ago
Kristina Kehoe, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4081 Meath Ct, Dublin, OH 43016 Phone: 318-214-7800 | |
San Yip, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 6840 Perimeter Dr, Dublin, OH 43016 Phone: 614-827-8700 Fax: 614-827-8701 | |
Avathar Smucker, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5130 Bradenton Ave Ste B, Dublin, OH 43017 Phone: 614-336-8733 | |
Ann Kurtenbach, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 6955 Hospital Dr, Dublin, OH 43016 Phone: 614-566-3489 | |
Becca Carlson, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6355 Emerald Pkwy, Dublin, OH 43016 Phone: 614-763-6431 | |
Rehabilitex Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4175 Stoneridge Lane, Dublin, OH 43017 Phone: 614-504-4733 Fax: 440-498-9725 |